Menu
In progress
In progress
Next step
In 2021, the analgesic drug market was worth71.3 billion dollars.
An average increase of 3.92% per year is expected between 2022 and 2030.
Pain management is the health challenge of the 21st century!
Tafalgie Therapeutics is a CNRS and AMU spin-off company engaged in biopharmaceutical research and committed to developing a new scientific approach for next-generation treatments based on a ground-breaking innovation : a mechanism of action derived from an endogenous secreted protein capable of modulating pain signals.